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Abstract
Background: Body fat mass distribution and deposition are determined by multiple environmental and
genetic factors. Obesity is associated with insulin resistance, hyperinsulinemia, and type 2 diabetes. We
previously identified evidence for genotype-by-diabetes interaction on obesity traits in Strong Heart Family
Study (SHFS) participants. To localize these genetic effects, we conducted genome-wide linkage scans of
obesity traits in individuals with and without type 2 diabetes, and in the combined sample while modeling
interaction with diabetes using maximum likelihood methods (SOLAR 2.1.4).
Methods: SHFS recruited American Indians from Arizona, North and South Dakota, and Oklahoma.
Anthropometric measures and diabetes status were obtained during a clinic visit. Marker allele frequencies
were derived using maximum likelihood methods estimated from all individuals and multipoint identity by
descent sharing was estimated using Loki. We used variance component linkage analysis to localize
quantitative trait loci (QTLs) influencing obesity traits. We tested for evidence of additive and QTL-specific
genotype-by-diabetes interactions using the regions identified in the diabetes-stratified analyses.
Results: Among 245 diabetic and 704 non-diabetic American Indian individuals, we detected significant
additive gene-by-diabetes interaction for weight and BMI (P < 0.02). In analysis accounting for QTL-specific
interaction (P < 0.001), we detected a QTL for weight on chromosome 1 at 242 cM (LOD = 3.7). This
chromosome region harbors the adiponectin receptor 1 gene, which has been previously associated with
obesity.
Conclusion: These results suggest distinct genetic effects on body mass in individuals with diabetes
compared to those without diabetes, and a possible role for one or more genes on chromosome 1 in the
pathogenesis of obesity.
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Background
Body fat mass distribution and deposition are determined
by multiple environmental and genetic factors. Obesity is
associated with insulin resistance, hyperinsulinemia, and
incident type 2 diabetes [1,2]. Moreover, insulin has ana-
bolic effects on fat metabolism leading to fat deposition
and obesity [3]. Obesity and diabetes are highly prevalent
in American Indian populations. Among individuals
between 45 and 74 years who were recruited into the
Strong Heart Study, approximately 35% were obese [4]
and type 2 diabetes prevalence varied by recruiting center
from 33% in South and North Dakota men to 72% in Ari-
zona women [5]. The estimated age-adjusted rates of dia-
betes were higher in recruiting centers with a higher
prevalence of obesity [5].
Diabetes and obesity are associated with increased mor-
bidity and mortality in the general population [6] and
among American Indian subjects, and they account for
increased incident hypertension [7], and fatal and nonfa-
tal cardiovascular disease (CVD) events [8]. The identifi-
cation of genes for obesity in the environmental and
genetic milieu of type 2 diabetes may bring us one step
closer to the identification of the functional genes that
influence susceptibility to obesity, a major public health
problem among American Indian populations.
The genetic component of obesity-related traits among
American Indians has been previously described [9-11].
In our previous work [11], we identified evidence for dis-
tinct genetic effects on obesity related traits in diabetic
compared to non-diabetic Strong Heart Family Study
(SHFS) participants. A significant additive genotype-by-
diabetes interaction was observed for body mass index
(BMI), waist-to-hip ratio (WHR) and percent body fat.
The purpose of the present study is to localize these
genetic effects on obesity-related traits while accounting
for interaction with diabetes status.
Methods
The SHFS recruitment and genotyping methods have been
described elsewhere [12,13]. Briefly, American Indian
subjects from 13 tribes were recruited from centers located
in Arizona, Oklahoma and North and South Dakota.
Clinical information and laboratory measures were
obtained during a study exam. Anthropometric measures
of body weight (kg) and height (m) were used to estimate
BMI (kg/m2). WHR (in cm) was also recorded. Percentage
body fat was measured using Quantum II bioelectric
impedance (RJL Systems, Clinton Township, MI) [12].
The percentage of body fat was calculated using a formula
based on total body water [13]. Type 2 diabetes was
defined as a fasting blood glucose of 126 mg/dl or higher,
history of diabetes or use of diabetic medications [14].
The SHFS protocols were approved by the Indian Health
Service Institutional Review Board (IRB), the IRBs from
participating institutions and by the 13 tribes participat-
ing in these studies. The study was conducted in accord-
ance with the principles of the Declaration of Helsinki.
Written consent was obtained from all individuals of this
study.
Participants, who are members of extended families, were
genotyped for approximately 400 microsatellite markers
spaced at average 10 cM intervals across the autosomal
chromosomes. Pedigree relationships were verified using
the Pedigree Relationship Statistical Tests program [15],
which employs likelihood-based inference statistics for
genome-wide identity-by-descent (IBD) allele sharing.
Mendelian inconsistencies and spurious double recom-
binants were detected using the SimWalk2 program [16].
The overall blanking rate for both types of errors was less
than 1% of the total number of genotypes for Arizona,
Dakota and Oklahoma. Marker allele frequencies were
estimated using maximum likelihood methods estimated
from all individuals [17] and multipoint IBD sharing was
estimated using Loki software [18].
We conducted a genome scan of obesity traits while mod-
eling interaction with diabetes status using maximum
likelihood methods implemented in SOLAR 2.1.4. We
studied 976 individuals from extended families enrolled
between 1998 and 1999 (SHS phase 3). We examined the
distribution of the obesity-related quantitative traits of
body weight, BMI, WHR and percentage of body fat, and
excluded observations greater than 2.5 standard devia-
tions above or below the mean (< 5 observations
excluded). The traits were adjusted for the effects of age,
age2, sex, age-by-sex interaction and study center using
linear regression models and an alpha = 0.05. The WHR
trait was scaled for analysis by multiplying by 10.
We examined the evidence for additive genotype-by-dia-
betes interaction on obesity traits using maximum likeli-
hood variance decomposition methods extended to allow
for the genetic covariance between diabetic and non-dia-
betic subjects [19,20]. We tested the hypothesis of interac-
tion using the likelihood ratio test comparing a model
including genotype-by-diabetes interaction to restricted
models in which such interaction is excluded. We esti-
mated the genetic correlation between diabetic and non-
diabetic individuals (ρG) and the genetic standard devia-
tions for diabetic and non-diabetic subjects. To test for dif-
ferential additive genetic effects among diabetic and non-
diabetic subjects, we compared a model in which ρG (dia-
betic, non-diabetic) =1 to a model without constraints. To
test for differences in the magnitude of the genetic effects
among diabetic and non-diabetic subjects, we compared a
model in which the genetic standard deviations of the two
groups are constrained to be equal to a model withoutBMC Medical Genetics 2008, 9:90 http://www.biomedcentral.com/1471-2350/9/90
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these constraints. We considered evidence for genotype-
by-environment interaction if the genetic correlation
between diabetics and non-diabetics was different than 1
and/or the genetic variance for obesity traits in diabetics
was significantly different than in non-diabetics.
We also tested for QTL-specific diabetes-by-obesity inter-
action. For these analyses, we compared a model in which
the QTL standard deviations are constrained to be equal,
to a model without constraints, using the likelihood ratio
statistics. When comparing models with variances con-
strained to be equal, interpretation of significant differ-
ences were based on the assumption of an asymptotic chi-
square distribution for the likelihood test statistic. For
models that restricted the genetic correlation to one (the
upper boundary of the parameter space, i.e., ρG = 1.0), the
test statistic is asymptotically distributed as a 50:50 mix-
ture of a chi-square and a point mass at 0 [19]. The gene-
by-environment analysis has an additional QTL variance
component compared with the standard linkage model,
therefore we corrected for the increase in degrees of free-
dom and all reported LOD scores are corrected LOD score
[21].
For the obesity traits showing significant additive geno-
type-by-diabetes interaction at alpha = 0.05 (ρG ≠ 1), we
performed genome scans accounting for the diabetes
interaction. We adjusted the obtained LOD scores for the
difference in the number of parameters between the poly-
genic and linkage versions of the interaction model, tak-
ing into account that each of the QTL standard deviations
has a boundary at the null hypothesis.
We used the University of California Santa Cruz http://
genome.ucsc.edu and the miRBase database http://micro
rna.sanger.ac.uk/ websites to search for candidate genes
and microRNAs.
Results
Over 10,000 relative-pairs were available for analysis
(Table 1). Approximately 57% of participants were obese
(BMI > 30 kg/m2) and 26% had diabetes (Table 1). Indi-
viduals with diabetes had higher mean weight, BMI, WHR
and percentage of body fat than those without diabetes.
Approximately 62% of diabetic subjects were using oral
hypoglycemic drugs or insulin therapy.
We detected significant additive genotype-by-diabetes
interaction for weight (ρG ≠ 1, p = 0.01), BMI (p = 0.0002)
and WHR (p = 0.02), suggesting that at least some of the
genes influencing these obesity traits differed in diabetic
compared to non-diabetic subjects (Table 2).
Analysis accounting for the genotype-by-diabetes interac-
tion identified a QTL for weight on chromosome 1 at 242
cM (marker D1S249, LOD = 3.7) (Figure 1). For compar-
ison, the diabetes-specific signal at 1q32 for other obesity-
related traits is also shown in Figure 1. Stratified analyses
by diabetes showed that the chromosome 1 signal was
more prominent in diabetic subjects (LOD = 2.7) (Figure
2). The 1-LOD support interval was between D1S238 and
D1S425 covering the regions 1q31.1-q32.2, and approxi-
mately 23.8 MB. Additional QTLs identified in our linkage
analysis of obesity traits accounting for diabetes status are
reported in the Additional file 1.
We then evaluated the evidence for genotype-by-diabetes
interaction at the QTL level, using the combined samples
of diabetic and non-diabetic individuals and the maxi-
mum LOD score QTL identified on the diabetes-stratified
analysis. The QTL- specific genotype-by-diabetes interac-
tion was significant for weight on chromosome 1 at 242
cM (p for interaction < 0.001).
Discussion
This study identified a diabetes-specific QTL for body
weight on chromosome 1 among American Indians,
which was less prominent for BMI and for the fat distribu-
tion trait of WHR. Diabetes and obesity are strongly asso-
ciated in American Indian and other populations, and
environmental factors such as diet and lifestyle play an
important role in both conditions. Our findings suggest a
role for diabetes-specific genes influencing body fat depo-
sition in American Indians. Further studies are required to
Table 1: Descriptive characteristics of American Indian subjects by diabetes status
Overall participants Diabetic individuals Non-diabetic Individuals
Number 976 255 721
Mean age (SD) 42 (16) 53 (14) 38 (15)
Sex female/male 563/400 156/94 407/306
Mean Weight (kg) (SD) 88.7 (20.9) 91.4 (20.4) 87.7 (21.0)
Mean BMI (kg/m2) (SD) 31.8 (7.0) 33.7 (6.6) 31.1 (7.0)
Mean % body fat (SD) 36.5 (9.8) 38.4 (8.6) 35.9 (10.1)
Mean WHR (SD) 0.93 (0.09) 0.97 (0.06) 0.92 (0.09)
Number of relative-pairs 10,271 598 6,303
BMI, body mass index; WHR, waist-to-hip ratio; SD, standard deviationBMC Medical Genetics 2008, 9:90 http://www.biomedcentral.com/1471-2350/9/90
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explore the generalizability of these findings to popula-
tions of different ethnic/racial and cultural backgrounds,
in which the prevalence of obesity and diabetes vary from
American Indians. Nevertheless, our findings suggest that
the genetic susceptibility to obesity and type 2 diabetes
may share common genetic pathways, by complex inter-
actions of genes influencing obesity in the milieu of dia-
betes.
Several prior studies have showed linkage to the chromo-
some 1 region for diabetes-related traits and obesity [22],
although genetic interactions have not been explored at
this QTL. The 1q32 region was identified in linkage anal-
ysis of type 2 diabetes in African American participants of
the Hypertension Genetic Epidemiology Network (Hyper-
GEN) (LOD = 1.9) [23]. Among non-diabetic individuals,
linkage to this QTL was described in studies of fasting glu-
Table 2: Additive genotype-by-diabetes interaction for obesity related quantitative traits in American Indian participants of the Strong 
Heart Family Study
Genetic standard deviation
Obesity traits Variance due to 
covariates*
Residual kurtosis 
after covariates
Genetic correlation (ρG) 
± SE among diabetics and 
nondiabetics (P-value)
Diabetic individuals Non-diabetic 
individuals
P-value**
Weight 0.11 0.55 0.56 ± 0.16 (0.01) 15.56 18.83 0.26
BMI 0.09 0.75 0.45 ± 0.17 (0.0002) 6.26 5.56 0.50
% FAT 0.47 0.96 0.67 ± 0.18 (0.08) 5.58 7.46 0.16
WHR† 0.22 0.57 0.72 ± 0.15 (0.02) 5.77 5.51 0.77
BMI, body mass index; WHR, waist-to-hip ratio; FAT, body fat; SE, standard error. * age, sex, center; ** P-values for the likelihood ratio comparing 
a model in which the genetic variances for obesity traits in diabetics and non-diabetics are equal to a model without constrains. †The trait was 
scaled by multiplying by 100.
Multipoint LOD Scores on Chromosome 1 for Obesity Traits Accounting for Diabetes Interaction Figure 1
Multipoint LOD Scores on Chromosome 1 for Obesity Traits Accounting for Diabetes Interaction. Adjusted for 
age, age2, sex, age-by-sex interaction within centers.
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cose among Pima Indians (LOD = 1.5) [24] and among
participants of the Framingham Offspring Study (LOD =
1.8) [25], and in studies of fasting insulin among Hyper-
GEN males (LOD = 2.1) [26]. In addition, a West African
study of type 2 diabetic sib-pairs described a LOD score of
1.6 for BMI and 1.5 for fat mass (estimated by bioelectric
impedance), between the 1q25.1-q31.1 regions, which
are within the 1-LOD score support region of our linkage
peak [22]. Participants in this West African study were
about 5 BMI units heavier than the population from
which they were enrolled [22].
Within the 1-LOD support region lays the ADIPOR1 gene.
The adiponectin 1 receptor mediates adiponectin effects
on fatty acid oxidation and glucose uptake through activa-
tion of AMP-activated protein kinase and peroxisome pro-
liferator-activated receptor-α [27]. ADIPOR1 deficient (-/-
) mice show increased adiposity and decreased glucose
tolerance, associated with decreased locomotor activity
and energy expenditure [27]. ADIPOR1  variants have
been associated with type 2 diabetes, pre-diabetes states
and measures of obesity although not in all studies [28-
33]. For example, among Caucasian obese individuals
(mean BMI 32 kg/m2) with impaired glucose tolerance,
ADIPOR1 SNPs were associated with measures of body
size including weight, waist, hip circumference and BMI
[30]. In addition, a gene-gene interaction of ADIPOR1
and ADIPONECTIN was observed in increased overall and
abdominal adiposity and higher substrate oxidation [34].
Therefore, ADIPOR1 is a potential candidate gene for plei-
otropic effects on obesity and diabetes susceptibility in
humans.
It is difficult to gauge the LOD score evidence reported
herein in the face of the number of comparisons made in
conducting gene-by-diabetes genome scans. In total, we
conducted three genome scans (a minimum model, a
maximal model and an interaction model). If we were to
use a too conservative Bonferoni correction, we would
need to observe a P = 0.05/3 * 380 markers: P = 0.00004
or a corresponding LOD score of 3.7. However, given the
correlation and non-independence of the three genome
scans of each obesity trait, a systematic correction would
be extremely difficult.
Multiple interacting genes may underlie this QTL on chro-
mosome 1, and therefore, densely genotyping this region
is the next logical step to be taken to identify these genes
Multipoint LOD Scores on Chromosome 1 for Weight by Diabetes Status Figure 2
Multipoint LOD Scores on Chromosome 1 for Weight by Diabetes Status. Adjusted for age, age2, sex, age-by-sex 
interaction within centers.
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influencing obesity in the context of diabetes. Our find-
ings are limited to American Indian populations and
should be validated in replication samples of other popu-
lations.
Conclusion
In summary, we identified a diabetes-specific QTL on
chromosome 1 at 242 cM for weight in American Indians,
in the region where the ADIPOR1 gene is located. This
gene has been associated with multiple measures of body
size and diabetes-related traits in humans and experimen-
tal models and, therefore, it is likely a good candidate for
susceptibility to fat deposition in diabetic individuals.
Importantly, our findings support that this region of the
genome likely harbors susceptibility variants for obesity
that are importantly different in type 2 diabetes individu-
als and those with normal glucose metabolic profile.
Thus, future studies should more comprehensively evalu-
ate the ADIPOR1 gene, especially with respect to the com-
plex relationship between body weight and type 2
diabetes.
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